BENUSSI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 4.434
EU - Europa 1.794
AS - Asia 937
SA - Sud America 9
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 2
Totale 7.188
Nazione #
US - Stati Uniti d'America 4.424
CN - Cina 520
IT - Italia 461
UA - Ucraina 348
DE - Germania 294
HK - Hong Kong 238
GB - Regno Unito 171
FI - Finlandia 152
SG - Singapore 128
IE - Irlanda 123
FR - Francia 74
CZ - Repubblica Ceca 39
RU - Federazione Russa 39
BE - Belgio 36
IN - India 18
PL - Polonia 16
SE - Svezia 14
TR - Turchia 13
AU - Australia 8
BR - Brasile 8
CA - Canada 8
NL - Olanda 8
TW - Taiwan 7
ES - Italia 5
EU - Europa 4
IR - Iran 4
DK - Danimarca 3
JP - Giappone 3
RO - Romania 3
AT - Austria 2
GR - Grecia 2
SA - Arabia Saudita 2
VN - Vietnam 2
AL - Albania 1
AW - Aruba 1
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
ID - Indonesia 1
MU - Mauritius 1
NO - Norvegia 1
PT - Portogallo 1
SL - Sierra Leone 1
Totale 7.188
Città #
Fairfield 698
Woodbridge 384
Ashburn 333
Chandler 318
Jacksonville 294
Wilmington 252
Cambridge 247
Seattle 246
Houston 237
Hong Kong 234
Ann Arbor 226
Princeton 200
New York 197
Helsinki 144
Dublin 123
Beijing 108
Nanjing 81
Brescia 77
Dearborn 75
Singapore 69
Milan 64
Shanghai 58
Brussels 36
Des Moines 36
Jinan 35
Nanchang 35
San Diego 35
Hebei 33
Boardman 32
Los Angeles 30
Shenyang 28
Olomouc 27
Changsha 26
London 22
Lancaster 19
Norwalk 15
San Francisco 15
San Mateo 15
Warsaw 15
Rome 14
Ningbo 13
Augusta 12
Brno 12
Romola 12
Taizhou 12
Hangzhou 11
Jiaxing 11
Kocaeli 11
Kunming 11
Guangzhou 9
Torino 8
Trieste 8
Chiswick 7
Haikou 7
Mumbai 7
Munich 7
Rende 7
Taiyuan 7
Tianjin 7
Washington 7
Bergamo 6
Leawood 6
Taipei 6
Castelli Calepio 5
Honolulu 5
La Loggia 5
Lucca 5
Monmouth Junction 5
Orange 5
San Giuliano Terme 5
São Paulo 5
Toronto 5
Fuzhou 4
Gunzenhausen 4
Iseo 4
Islington 4
Kilburn 4
La Seyne-sur-Mer 4
Naples 4
Nürnberg 4
Parma 4
Redwood City 4
Venezia 4
Verona 4
Zhengzhou 4
Arezzo 3
Avigliana 3
Bienno 3
Cagliari 3
Chicago 3
Cisano Bergamasco 3
Falkenstein 3
Frankfurt am Main 3
Lanzhou 3
Lappeenranta 3
Lodi 3
Mantova 3
Melbourne 3
Prescot 3
Rio Saliceto 3
Totale 5.479
Nome #
Discrimination of atypical parkinsonisms with transcranial magnetic stimulation 162
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 155
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 145
Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia 142
Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation 141
COVID-19 impact on consecutive neurological patients admitted to the emergency department 141
Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy 122
Metodo di generazione di un indice diagnostico per malattia di alzheimer, apparato elettronico di implementazione del metodo e sistema 120
Autoimmunity and frontotemporal dementia 119
Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial 118
Response to comments on natural history and predictors of survival in progressive supranuclear palsy 113
Sensitivity and specificity of transcranial magnetic stimulation for differential diagnosis of Alzheimer’s disease and frontotemporal dementia 110
Phenotypic heterogeneity of Niemann-Pick disease type C in monozygotic twins. 109
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 106
Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C. 104
Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. 102
Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia. 102
Cerebellar transcranial direct current stimulation in patients with ataxia: A double-blind, randomized, sham-controlled study. 101
Cerebrospinal fluid tau levels predict prognosis in non-inherited frontotemporal dementia. 101
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 99
The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease 98
Natural history and predictors of survival in progressive supranuclear palsy. 96
Clinical, genetic, and neuroimaging features of Early Onset Alzheimer Disease: the challenges of diagnosis and treatment. 95
Multimodal Brain Analysis of Functional Neurological Disorders: A Functional Stroke Mimic Case Series. 94
Modulating risky decision-making in Parkinson's disease by transcranial direct current stimulation. 94
Method of generation of a diagnostic index for Alzheimer disease, electronic apparatus for implementation of the method and system 93
Impaired long-term potentiation-like cortical plasticity in presymptomatic genetic frontotemporal dementia. 92
Facial feedback and autonomic responsiveness reflect impaired emotional processing in Parkinson's Disease. 92
The impact of TMS on the differential diagnosis and progression of dementia 92
Enhancing theory of mind in behavioural variant frontotemporal dementia with transcranial direct current stimulation 92
Variability and predictors of response to continuous theta burst stimulation: A TMS-EEG study 91
Modulation of long-term potentiation-like cortical plasticity in the healthy brain with low frequency-pulsed electromagnetic fields 91
Mild cognitive impairment in Parkinson's disease is improved by transcranial direct current stimulation combined with physical therapy. 90
Biological, Neuroimaging, and Neurophysiological Markers in Frontotemporal Dementia: Three Faces of the Same Coin. 90
Embedded platform-based system for early detection of Alzheimer disease through transcranial magnetic stimulation 89
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy. 88
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 88
Toward a Glutamate Hypothesis of Frontotemporal Dementia 87
Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure 85
Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 82
Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38 81
Csf p-tau181/tau ratio as biomarker for TDP pathology in frontotemporal dementia. 80
Transcranial Magnetic Stimulation in Alzheimer's Disease and Cortical Dementias 79
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 79
TMS for staging and predicting functional decline in frontotemporal dementia 76
Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial 75
Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC 74
CSF p-Tau181/Tau ratio to distinguish FTLD-TDP from FTLD-Tau 74
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 72
CSF p-Tau181/Tau ratio as biomarker for TDP pathology in Frontotemporal Dementia 71
Cerebello-spinal stimulation in neurodegenerative ataxia: A randomized, double-blind, sham-controlled, crossover trial 70
Serum neurofilament light in professional soccer players: goal on safety 69
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 69
Clinical and neurophysiological characteristics of heterozygous NPC1 carriers 69
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: Impact on diagnostic confidence and diagnostic accuracy 66
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 61
Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias 59
Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia 59
Prevalence of cerebrospinal fluid Alzheimer disease-like pattern in atypical dementias 58
Recent advances in understanding frontotemporal degeneration 55
Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias 52
Cortical Inhibitory Imbalance in Functional Paralysis 52
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 49
New insights into the genetic etiology of Alzheimer’s disease and related dementias 45
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 44
Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial 43
Classification accuracy of TMS for the diagnosis of mild cognitive impairment 42
Voluntary inhibitory control and impulsivity in Parkinson’s disease patients with and without levodopa-induced dyskinesias 41
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 41
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration 39
Diagnostic Accuracy of the Five-Word Test for Mild Cognitive Impairment Due to Alzheimer’s Disease 37
Clinical and radiological features of posterior cortical atrophy (PCA) in a GRN mutation carrier: a case report 36
Effects of COVID-19 outbreak on stroke admissions in Brescia, Lombardy, Italy 36
Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19 36
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 34
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 34
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 34
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 33
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 33
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 32
Non-invasive cerebellar stimulation in neurodegenerative ataxia: A literature review 32
Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study 32
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves 32
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 31
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia 29
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 29
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 28
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 27
Hyperconnectivity in Dementia Is Early and Focal and Wanes with Progression 26
Differential early subcortical involvement in genetic FTD within the GENFI cohort 25
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study 24
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 24
Neurotransmitter imbalance dysregulates brain dynamic fluidity in frontotemporal degeneration 24
Aberrant origin of the occipital artery from the internal carotid artery: utility of the occipital tap maneuver 24
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 24
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 24
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 24
The role of transcranial magnetic stimulation in the diagnosis of dementia 24
Citicoline Treatment in Acute Ischemic Stroke: A Randomized, Single-Blind TMS Study 23
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration 23
Totale 6.949
Categoria #
all - tutte 50.830
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.540 0 0 77 175 116 198 198 192 171 253 82 78
2020/20211.429 54 142 58 116 148 127 66 149 126 204 176 63
2021/2022861 61 71 27 34 10 52 86 82 55 97 100 186
2022/20231.071 121 65 48 71 76 244 24 89 148 55 65 65
2023/20241.216 78 32 148 72 37 239 32 55 248 35 35 205
2024/202588 46 19 23 0 0 0 0 0 0 0 0 0
Totale 7.412